MAP3K5 and rheumatoid arthritis: The level of phosphorylated JNK was significantly increased after treatment with anti-Fas antibody in the CRABP2 suppressed RA FLS in a way consistent with the activation of the pathway including activation of ASK1 (Fig. 4D, p = 0.03).